The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 353, Issue 6, 1996, Pages 630-640

  Arborelius, Lotta ^a   Nomikos, George G ^a   Hertel, Peter ^a   Salmi, Peter ^b   Grillner, Pernilla ^a   Backlund Höök, Berit ^c   Hacksell, Uli ^c   Svensson, Torgny H ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Astra Areus AB ^*  (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

(S) UH 301; 5 HT1A receptor antagonist; Antidepressant; Citalopram; Frontal cortex; Microdialysis; Serotonin

Indexed keywords

2 DIPROPYLAMINO 5 FLUORO 8 HYDROXYTETRALIN; 5 HYDROXYINDOLEACETIC ACID; ANTIDEPRESSANT AGENT; CITALOPRAM; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; DRUG DERIVATIVE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DORSAL RAPHE NUCLEUS; DOSE RESPONSE; DRUG POTENTIATION; FEEDBACK SYSTEM; FRONTAL CORTEX; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; RAT; SEROTONIN RELEASE; SINGLE UNIT ACTIVITY; SUBCUTANEOUS DRUG ADMINISTRATION; ANALYSIS OF VARIANCE; ANIMAL; BODY TEMPERATURE; DRUG EFFECT; EXTRACELLULAR SPACE; METABOLISM; RAPHE NUCLEUS; WISTAR RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANALYSIS OF VARIANCE; ANIMALS; BODY TEMPERATURE; CITALOPRAM; EXTRACELLULAR SPACE; MALE; MICRODIALYSIS; RAPHE NUCLEI; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0029664774     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00167182     Document Type: Article

References (57)

1. Adell A, Artigas F (1991) Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. Naunyn-Schmiedeberg's Arch Pharmacol 343:237-244
2. Aghajanian GK (1995) Electrophysiology of serotonin receptor subtypes and signal transduction pathways. In Bloom FE, Kupfer DJ (eds), Psychopharmacology: Fourth Generation of Progress, Raven Press, New York, pp 451-460
3. Aghajanian GK, Wang RY, Baraban J (1978) Serotonergic and non-serotonergic neurons of the dorsal raphe: reciprocal changes in firing induced by peripheral nerve stimulation. Brain Res 153:169-175
4. 1A receptor antagonist (S)-UH-301 blocks the (R)-8-OH-DPAT-induced inhibition of serotonergic dorsal raphe cell firing. J Neural Transm (GenSect) 96: 179-186
5. 1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rat treated acutely or chronically with citalopram. Naunyn-Schmideberg's Arch Pharmacol 352: 157-165
6. Arnt J, Fredricson Overö K, Hyttel J, Olsen R (1984) Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram. Psychopharmacology 84:457-465
7. Artigas F (1993) 5-HT and antidepressants: new views from microdialysis studies. Trends Pharmacol Sci 14:262
8. Artigas F, Perez V, Alvarez H (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 51:248-251
9. Bel N, Artigas F (1992) Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur J Pharmacol 229:101-103
10. Bel N, Artigas F (1993) Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15:243-245
11. Björk L, Cornfield LJ, Nelson DL, Hillver S-E, Andén N-E, Lewander T, Hacksell U (1991) Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-2- (dipropylamino)-tetralin: Inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects. J Pharmacol Exp Ther 258: 58-65
12. Blier P, de Montigny C (1994) Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15:220-226
13. Blier P, Bergeron R (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 15:217-222
14. Blier P, de Montigny C, Chaput Y (1987) Modifications of the serotonin system by antidepressant treatment: implications for the therapeutic response in major depression. J Clin Psychopharmacol 7:24S-35S
15. 1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats. Psychopharmacology 117:358-363
16. Bosker FJ, Klompmakers AA, Westenberg HGM (1995b) Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat. Neuropharmacology 34:501-508
17. Briley M, Moret C (1993) Neurobiological mechanisms involved in antidepressant therapies. Clin Neuropharmacol 16:387-400
18. 3H]cyanoimipramine autoradiography. In Langer SZ, Galzin AM, Costentin J (eds), Presynaptic receptors and neuronal transporters, Pergamon Press, Oxford, pp 233-234
19. Caccia S, Cappi M, Fracasso C, Garattini S (1990) Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology 100:509-514
20. Carboni E, Di Chiara G (1989) Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience 32:637-645
21. Chaput Y, de Montigny C, Blier P (1986) Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 33:342-348
22. Deakin JFW, Graeff FG (1991) 5-HT and mechanisms of defence. J Psychopharmacol 5:305-315
23. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR (1990) Serotonin function and the mechanism of antidepressant action. Arch Gen Psychiatry 47:411-418
24. 1A receptor agonists: recent developments and controversial issues. Psychopharmacology 121:1-26
25. Di Chiara G (1990) In-vivo brain dialysis of neurotransmitters. Trends Pharmacol Sci 11:116-121
26. Fredricson Overö K (1982) Kinetics of citalopram in test animals; drug exposure in saftey studies. Prog Neuro-Psychopharmacol Biol Psychiatry 6:297-309
27. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br J Pharmacol 115:1064-1070
28. 3H]paroxetine binding to cerebral cortical membranes of the rat. Neuropharmacology 26:1087-1092
29. Hajós M, Gartside SE, Sharp T (1995) Inhibition of median and dorsal raphe neurones following administration of the selective reuptake inhibitor paroxetine. Naunyn-Schmiedeberg's Arch Pharmacol 351:624-629
30. 1A receptor regulation. Neuropsychopharmacology 4:131-144
31. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. J Neurochem 60:776-779
32. 1A autoreceptors in the action of selective serotonin reuptake inhibitors. Eur J Pharmacol 260:251-255
33. 1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis. Neuropharmacology 33:331-334
34. Hjorth S, Auerbach SB (1995) Chronic citalopram effects on extracellular 5-HT and apparent autoreceptor sensitivity in vivo. Psychopharmacology 118:B13
35. Hyttel J (1982) Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuro-Psychopharmacol Biol Psychiatry 6:277-295
36. Hyttel J (1994) Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 9[Suppl 1]:19-26
37. Hyttel J, Fredricson Overö K, Arnt J (1984) Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. Psychopharmacology 83: 20-27
38. Invernizzi R, Belli S, Samanin R (1992) Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res 584:322-324
39. 1A receptors. Eur J Pharmacol 260:243-246
40. Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattaccini CM, Vantalon V, Laporte AM, Adrien J, Gozlan H, Hamon M (1994) Central pre- and postsynaptic 5- HT1A receptors in rats treated chronically with the novel antidepressant, cericlamine. J Pharmacol Exp Ther 268:1432-1443
41. Kreiss DS, Lucki I (1995) Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J Pharmacol Exp Ther 274:866-876
42. Lecrubier Y (1993) Antidepressant drugs: Similar but different? In Mendlewicz J, Brunello N, Langer SZ, Racagni G (eds), New pharmacological approaches to the therapy of depressive disorders. vol. 5, Int Acad Biomed Drug Res. Karger, Basel, pp 83-91
43. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn-Schmiedeberg's Arch Pharmacol 352:141-148
44. Middlemiss DN, Neill J, Tricklebank MD (1985) Subtypes of the 5-HT receptor involved in hypothermia and forepaw treading by 8-OH-DPAT. Br J Pharmacol 85:251P
45. Neuvonen P, Pohjola-Sintonen S, Tacke U, Vuori E (1993) Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses. Lancet 342:1419
46. 1A receptor antagonist (S)-UH-301 prevents (R)-8-OH-DPAT-induced decrease in interstitial concentrations of serotonin in the rat hippocampus. Eur J Pharmacol 216:373-378
47. O'Hearn E, Molliver ME (1984) Organization of raphe-cortical projections in the rat: a quantitative retrograde study. Brain Res Bull 13:709-726
48. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. 2nd edn. Academic Press, Sydney
49. Piñeyro G, Blier P, Dennis T, de Montigny C (1994) Desensitization of the neuronal 5-HT carrier following its long-term blockade. J Neurosci 14:3036-3047
50. Rigdon GC, Wang CM (1991) Serotonin uptake blockers inhibit the firing of presumed serotonergic dorsal raphe neurons in vitro. Drug Dev Res 22:135-140
51. 0 proteins in dorsal raphe nucleus. Eur J Pharmacol 265:103-106
52. Rutter JJ, Gundlah C, Auerbach SB (1994) Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxeline. Neurosci Lett 171:183-186
53. 1 agonists reduce 5-hydroxytryptamine release in rat hippocamus in vivo as determined by brain microdialysis. Br J Pharmacol 96:283-290
54. Sharp T, Bramwell SR, Grahame-Smith DG (1990) Release of endogenous 5-hydroxytryptamine in rat ventral hippocampus evoked by electrical stimulation of the dorsal raphe nucleus as detected by microdialysis: sensitivity to tedrodotoxin, calcium and calcium antagonists. Neuroscience 39:629-637
55. Sternbach H (1991) The serotonin syndrome. Am J Psychiatry 148:705-713
56. 2 receptors and transporter site for serotonin. Brain Res 615:87-94
57. 1A receptors in rat brain following antidepressant drug treatment. Synapse 4:347-352